Search Results
Answer created by AI
- Like
- Disike
AI result is experimental
Generating Answer...
-
Drug Manufacturers (8849)
-
Technology (5834)
-
Therapy Area (5831)
-
Clinical Trials (4437)
-
Covid-19 (3944)
-
Supply Chain (2512)
-
Infectious Disease (1503)
-
Regulation (1440)
-
Oncology (1337)
-
deal (1176)
-
Drug Development (1119)
-
Foreign Direct Investment (1075)
-
Impact of Chinas Zero COVID lockdowns (868)
-
Covid-19 Executive Briefing (735)
-
Approvals (664)
-
Sponsored (486)
-
Treatments (428)
-
The next chapter of clinical trial services (376)
-
Cytiva Pipe dream to pipeline WP 3 (360)
-
Suvoda WP (356)
No Filter Selected
-
News Analysis and Comments (40182)
-
Press Releases (3612)
-
White Papers (1101)
-
Supplier Products (951)
-
Suppliers (760)
-
Projects (759)
-
post_tag (736)
No Filter Selected
-
Clinical IT Systems (92)
-
Contract Manufacturers (69)
-
Lab Equipment (69)
-
Supply Chain (63)
-
Clinical Trials (55)
-
Pharmaceutical & Healthcare Packaging (51)
-
Process Automation and Equipment (42)
-
Drug Delivery Systems (39)
-
Clean Rooms and Cleanroom Flooring (37)
-
API Manufacturers (27)
-
Purification and Filtration (19)
-
Commercial Packaging (18)
-
Diagnostic Imaging (18)
-
Solid Dose Manufacturing (18)
-
API Biologics (Cell, Gene, Vaccine) (17)
-
Pharmaceutical Logistics and Supply Chain (16)
-
Cloud (14)
-
Pharma Benefit (14)
-
API Chemicals (12)
-
Injectables (commercial dose) (12)
No Filter Selected
-
United States (4511)
-
Europe (1551)
-
United Kingdom (1425)
-
North America (994)
-
Global (626)
-
China (606)
-
Asia-Pacific (479)
-
Japan (333)
-
Canada (243)
-
Germany (232)
-
Switzerland (227)
-
India (222)
-
UK (155)
-
France (139)
-
Australia (130)
-
US (104)
-
Russia (100)
-
Middle East and Africa (96)
-
South Korea (92)
-
Denmark (86)
No Filter Selected
-
Bristol-Myers Squibb (378)
-
Merck (318)
-
Pfizer (282)
-
Novartis (265)
-
AstraZeneca (244)
-
F. Hoffmann-La Roche (200)
-
AbbVie (178)
-
BeiGene (148)
-
Eli Lilly and Co (148)
-
GSK (137)
-
Johnson & Johnson (132)
-
Amgen (128)
-
Gilead Sciences (111)
-
Incyte (107)
-
Boehringer Ingelheim International (103)
-
Daiichi Sankyo (93)
-
Exelixis (91)
-
Jiangsu Hengrui Medicine (89)
-
Takeda Pharmaceutical (89)
-
Sanofi (87)
No Filter Selected
-
Achondroplasia (1)
-
Acinetobacter Infections (3)
-
Acne Vulgaris (3)
-
Acquired Hemophilia A (1)
-
Acromegaly (1)
-
Acute Ischemic Stroke (6)
-
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (1)
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (5)
-
Acute On Chronic Liver Failure (ACLF) (1)
-
Acute Opioid Overdosage (1)
-
Acute Renal Failure (ARF) (Acute Kidney Injury) (2)
-
Acute Respiratory Distress Syndrome (1)
-
Acute Sensorineural Hearing Loss (1)
-
Acute Spinal Cord Injury (1)
-
Adenocarcinoma (1)
-
Adrenocortical Carcinoma (Adrenal Cortex Cancer) (1)
-
Adrenomyeloneuropathy (AMN) (1)
-
Alcoholic Hepatitis (2)
-
Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency) (1)
-
Allergic Asthma (2)
No Filter Selected
-
(Aceclidine + brimonidine) (1)
-
(Acetaminophen + naltrexone) (1)
-
(Acetaminophen + nefopam hydrochloride) (1)
-
(Allopurinol +verinurad) (1)
-
(Amlodipine + fimasartan potassium) (1)
-
(Amlodipine + indapamide + telmisartan) (1)
-
(Arginine + sodium succinate) (1)
-
(Atorvastatin + ezetimibe) (1)
-
(Atorvastatin + fluconazole + minocycline) (2)
-
(Avibactam + aztreonam) (8)
-
(Avibactam tomilopil + ceftibuten) (1)
-
(Azacitidine + cedazuridine) (3)
-
(Benzoyl peroxide + tretinoin) (1)
-
(Betamethasone dipropionate + calcipotriene) (1)
-
(Bezafibrate + obeticholic acid) (1)
-
(Bizalimogene ralaplasmid + Mavilimogene ralaplasmid) (1)
-
(Bizalimogene ralaplasmid + mavilimogene ralaplasmid) (1)
-
(Borneol + edaravone) (1)
-
(Brimonidine tartrate + carbachol) (1)
-
(CST-2032 + nadolol) (1)
No Filter Selected
-
Artificial Intelligence (10)
-
Big Data (4)
-
Biosimilars (5)
-
Blockchain (1)
-
Cell & Gene Therapy (13)
-
Chemotherapy (1)
-
Cloud (1)
-
Corporate Governance (3)
-
Covid-19 (5)
-
Cybersecurity (4)
-
Digitalization (2)
-
Easy & Affordable (1)
-
Electronic Medical Record (EMR) Systems (1)
-
Environmental Sustainability (6)
-
Future of Work (3)
-
Genomics (10)
-
Health & Wellness (1)
-
Immuno-oncology (19)
-
Immunotherapy (1)
No Filter Selected
Digital transformation of the supply chain will make data more valuable - are you prepared?
The centre of gravity in the pharmaceutical industry is changing. But one common factor can help make supply chains more comprehensible, resilient and valuable: data
The importance of finding a versatile, scalable CDMO in the softgel market
In a crowded pharmaceutical market, seeking the right partners is a must to ensure a product is successful. Expert CDMO Sofgen provides end-to-end services that support the development of a range of projects, big or small.
Partnerships are key to driving digital healthcare transformation in US, say experts
Digital healthcare experts Huma emphasize the importance of collaboration among various stakeholders, including patients, providers, payers, and pharma companies, to drive transformation and achieve shared goals.
Can digital technology address US healthcare challenges?
Digital healthcare technology could lead to a more productive, proactive healthcare system with better outcomes for patients. What digital health technologies are currently available, and what are the upcoming technologies of the future? We asked digital healthcare specialists Huma for their insights.
Gen AI and its use in medical devices and SaMD
AI is fast becoming a valuable tool for developers of regulated health apps. In an exclusive Q&A, SaMD solutions provider Huma tells us how AI is allowing clinicians to make better decisions and why the human factor will remain a critical element of healthcare.
Novartis reports 25% increase in net income in Q1 2024
Operating income and net sales from continuing operations stood at $3.37bn and $11.8bn, respectively.
Hepion shelves Phase II NASH trial amid shallow cash resources
The future of Hepion’s ASCEND-NASH study was already in the balance following cost-cutting measures last December.
Social prescribing: friend or foe for pharma?
As awareness surrounding social prescribing grows, can this initiative go hand in hand with the pharmaceutical industry?
Investors advocate for early biotech partnerships for later deal success
At the Swiss Biotech Day conference, key opinion leaders discussed trends in pharmaceutical partnerships.
Targeting mouth cancer with light-activated drugs
LightOx explained how light-activated drugs can be used to treat cancer on day one of the BioTrinity 2024 conference in London.
EC approves BeiGene’s tislelizumab for three NSCLC indications
Tislelizumab is greenlit as a first-line treatment in combination with certain drugs for non-small cell lung cancer.
Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint
Sanofi’s rilzabrutinib met the primary endpoint in the Phase III persistent or chronic immune thrombocytopenia trial.
ImmunityBio's ANKTIVA receives FDA approval for bladder cancer
Based on the safety and efficacy results of a trial involving 77 evaluable patients, the FDA granted approval.
Ochre Bio and Boehringer enter CLD regenerative therapy deal
The deal value could surpass $1bn with Ochre Bio eligible for up to $35m in upfront and near-term milestone payments.
The top emerging pharmaceutical companies in the US
From Organon & Co to Denali Therapeutics, Pharmaceutical Technology lists the top ten emerging US pharmaceutical companies in 2023 based on their revenues.
Ipsen and Skyhawk partner to develop rare neurological therapies
Skyhawk is eligible to receive up to $1.8bn in payments tied to meeting development, regulatory, and commercial milestones.
EC approves Pfizer's Emblaveo for multidrug-resistant infections
Based on positive outcomes from the Phase III REVISIT and ASSEMBLE trials, the EC adopted its latest decision.
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
There is no excerpt because this is a protected post.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- 191
- 192
- 193
- 194
- 195
- 196
- 197
- 198
- 199
- 200
- 201
- 202
- 203
- 204
- 205
- 206
- 207
- 208
- 209
- 210
- 211
- 212
- 213
- 214
- 215
- 216
- 217
- 218
- 219
- 220
- 221
- 222
- 223
- 224
- 225
- 226
- 227
- 228
- 229
- 230
- 231
- 232
- 233
- 234
- 235
- 236
- 237
- 238
- 239
- 240
- 241
- 242
- 243
- 244
- 245
- 246
- 247
- 248
- 249
- 250
- 251
- 252
- 253
- 254
- 255
- 256
- 257
- 258
- 259
- 260
- 261
- 262
- 263
- 264
- 265
- 266
- 267
- 268
- 269
- 270
- 271
- 272
- 273
- 274
- 275
- 276
- 277
- 278
- 279
- 280
- 281
- 282
- 283
- 284
- 285
- 286
- 287
- 288
- 289
- 290
- 291
- 292
- 293
- 294
- 295
- 296
- 297
- 298
- 299
- 300
- 301
- 302
- 303
- 304
- 305
- 306
- 307
- 308
- 309
- 310
- 311
- 312
- 313
- 314
- 315
- 316
- 317
- 318
- 319
- 320
- 321
- 322
- 323
- 324
- 325
- 326
- 327
- 328
- 329
- 330
- 331
- 332
- 333
- 334
- 335
- 336
- 337
- 338
- 339
- 340
- 341
- 342
- 343
- 344
- 345
- 346
- 347
- 348
- 349
- 350
- 351
- 352
- 353
- 354
- 355
- 356
- 357
- 358
- 359
- 360
- 361
- 362
- 363
- 364
- 365
- 366
- 367
- 368
- 369
- 370
- 371
- 372
- 373
- 374
- 375
- 376
- 377
- 378
- 379
- 380
- 381
- 382
- 383
- 384
- 385
- 386
- 387
- 388
- 389
- 390
- 391
- 392
- 393
- 394
- 395
- 396
- 397
- 398
- 399
- 400
- 401
- 402
- 403
- 404
- 405
- 406
- 407
- 408
- 409
- 410
- 411
- 412
- 413
- 414
- 415
- 416
- 417
- 418
- 419
- 420
- 421
- 422
- 423
- 424
- 425
- 426
- 427
- 428
- 429
- 430
- 431
- 432
- 433
- 434
- 435
- 436
- 437
- 438
- 439
- 440
- 441
- 442
- 443
- 444
- 445
- 446
- 447
- 448
- 449
- 450
- 451
- 452
- 453
- 454
- 455
- 456
- 457
- 458
- 459
- 460
- 461
- 462
- 463
- 464
- 465
- 466
- 467
- 468
- 469
- 470
- 471
- 472
- 473
- 474
- 475
- 476
- 477
- 478
- 479
- 480
- 481
- 482
- 483
- 484
- 485
- 486
- 487
- 488
- 489
- 490
- 491
- 492
- 493
- 494
- 495
- 496
- 497
- 498
- 499
- 500